Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Trial to Evaluate if Tailored Antibiotic and Steroid Therapy Based on the Interleukin-6 (IL-6) Value in Amniotic Fluid Obtained by Amniocentesis in Patients With Premature Rupture of Membranes is Associated With Pregnancy Prolongation Compared to Standard Management.

NCT07107477 is registered in ClinicalTrials.gov with The Central and Eastern European Gynecologic Oncology Group as lead sponsor.

NCT NCT07107477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Trial to Evaluate if Tailored Antibiotic and Steroid Therapy Based on the Interleukin-6 (IL-6) Value in Amniotic Fluid Obtained by Amniocentesis in Patients With Premature Rupture of Membranes is Associated With Pregnancy Prolongation Compared to Standard Management.
Lead sponsor
The Central and Eastern European Gynecologic Oncology Group
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2025
Completion date
May 1, 2028
Enrollment
138 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

preterm premature rupture of membranes (pprom)